Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of brivaracetam tablet vs dry syrup in healthy Japanese males
jRCT2071210137Active, not recruiting
- Sponsor
- UCB
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of brivaracetam in epilepsy (2 arms), sponsored by UCB. Primary endpoints: Cmax of brivaracetam and AUC(0-t) of brivaracetam. Started Apr 2022; status: active, not recruiting.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT2071210137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210137.